ONWARD Medical Taps Veteran CFO Ali Kiboro to Navigate Growth Phase
Event summary
- Ali Kiboro appointed CFO of ONWARD Medical, effective January 2026.
- Kiboro brings 25 years of financial leadership experience in medical technology and diagnostics.
- Previously CFO at AliveDx, with senior roles at Quest Diagnostics and General Motors.
- ONWARD Medical develops spinal cord stimulation therapies, with FDA Breakthrough Device Designations.
- Company's ARC EX® System commercially available in the US and Europe.
The big picture
ONWARD Medical's appointment of Ali Kiboro as CFO underscores its focus on scaling operations and optimizing financial strategy during a critical growth phase. Kiboro's background in medical technology and diagnostics aligns with ONWARD's mission to restore movement and function through innovative neurotechnology. The move comes as the company advances its ARC EX® System and develops next-generation implantable systems, positioning itself in a competitive neurotechnology landscape.
What we're watching
- Scaling Strategy
- How Kiboro's experience in scaling life science companies will impact ONWARD Medical's growth trajectory.
- Capital Markets
- Whether Kiboro's capital markets expertise will accelerate ONWARD Medical's financial strategy.
- Commercialization Pace
- The pace at which ONWARD Medical can advance its ARC-IM® and ARC-BCI technologies under new financial leadership.